Much is riding on new drugs that may slow the disease, says Lord Abbett Partner and Research Analyst Lavina Talukdar.
Entries filed under 'Health Care'
Next-generation genomic sequencing should not only permit the use of new clinical applications that were not previously feasible but also save the healthcare system money.
How cost containment and efficiency initiatives have complicated investing in hospitals, managed care, and medical device companies.
Relentless innovation and ongoing mergers and acquisitions have created significant investment opportunities in the pharmaceuticals and biotechnology sectors.